Susan Branford
- Hematology top 0.02%
- Genetics top 0.02%
- Rheumatology top 0.05%
- Oncology top 2%
- Molecular Biology top 10%
- Co-authors
- Timothy P. HughesAndreas HochhausJerald P. RadichZbigniew RudzkiAndrew GriggJohn M. GoldmanFrançois GuilhotBrian Druker
- Topics
- Chronic Myeloid Leukemia Treatments (191 papers)Chronic Lymphocytic Leukemia Research (160 papers)Eosinophilic Disorders and Syndromes (89 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Susan Branford
197 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Hematology 9.7k
- Genetics 8.1k
- Rheumatology 5.3k
- Oncology 1.3k
- Molecular Biology 1.1k
Countries citing papers authored by Susan Branford
This map shows the geographic impact of Susan Branford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Branford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Branford more than expected).
Fields of papers citing papers by Susan Branford
This network shows the impact of papers produced by Susan Branford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Branford. The network helps show where Susan Branford may publish in the future.
Co-authorship network of co-authors of Susan Branford
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Branford. A scholar is included among the top collaborators of Susan Branford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Branford. Susan Branford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 37 | |
| 4 | 14 | |
| 5 | 5 | |
| 6 | 10 | |
| 7 | 24 | |
| 8 | 10 | |
| 9 | 15 | |
| 10 | 84 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 12 | |
| 14 | 17 | |
| 15 | 32 | |
| 16 | Early molecular response to nilotinib in patients who failed imatinib is associated with a higher probability of cytogenetic response in chronic myeloid leukemia (CML) | 1 |
| 17 | 1 | |
| 18 | 236 | |
| 19 | 288 | |
| 20 | 172 |
About Susan Branford
Susan Branford is a scholar working on Hematology, Genetics and Rheumatology, having authored 200 papers that have together received 11.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (191 papers), Chronic Lymphocytic Leukemia Research (160 papers) and Eosinophilic Disorders and Syndromes (89 papers). The work is most often cited by research in Hematology (9.7k citations), Genetics (8.1k citations) and Rheumatology (5.3k citations). Susan Branford has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Timothy P. Hughes, Andreas Hochhaus, Jerald P. Radich, Zbigniew Rudzki, Andrew Grigg, John M. Goldman, François Guilhot, Brian Druker, Kevin Lynch and John F. Seymour. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.